Alexander Morin, PhD, is Director of Strategic Communications at Annovis Bio, a clinical-stage biotechnology company advancing novel treatments for neurodegenerative diseases. Trained as a neuroscientist, he leads scientific and corporate communications across investor relations, media, and publishing, translating the complexity of the company’s science and research into narratives that resonate with patients, clinicians, and the scientific community.